|Articles|June 1, 2019
- Pharmaceutical Executive-06-01-2019
- Volume 39
- Issue 6
Pharmaceutical Executive, June 2019 Issue (PDF)
Click the title above to open the Pharmaceutical Executive June 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 7 years ago
Pharm Exec's Top 50 Companies 2019almost 7 years ago
The Argument for External Comparator Adoptionalmost 7 years ago
Pharma Medical Affairs: A Blueprint for Futurealmost 7 years ago
'Vision’ Quest: Leading Through Changealmost 7 years ago
Pharm Exec 50 Hints to Rest of ’19almost 7 years ago
Predicting the Future of European Health Policyalmost 7 years ago
A Critical Juncture for Antibiotic R&Dalmost 7 years ago
New Strategies Sought to Pay for Costly Curesabout 7 years ago
Site Payments: Drilling in on Forecast, Budget Issuesabout 7 years ago
Building the Startup Dream TeamAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Beyond JAK Inhibitors: Biologics Signal a New Era in Alopecia Areata
2
Pharma M&A Roundup: Incyte to Acquire Vega Therapeutics, Galmed Pharmaceuticals to Acquire Colospan, Johnson & Johnson Acquires Firefly Bio
3
Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI
4
Roche Enters $2.3 Billion Global Collaboration with Nurix Therapeutics to Co-Develop and Co-Commercialize Bexobrutideg
5